Earn CME/CE credits
Pre-Conference Event

SKIN OF COLOR UPDATE PRE-CONFERENCE VIRTUAL SYMPOSIUM

Reaching New Heights in the Management of Dermatologic Conditions in Patients With Skin of Color – Targeted Therapies and Individualized Approaches

THURSDAY, AUGUST 14, 2025 | 6:00 pm — 9:00 pm ET

Visit SOCU 2025 Register

Co-chaired by Dr. Andrew F. Alexis and Dr. Eliot F. Battle, this dynamic, case-based virtual symposium brings together leading experts in dermatology to spotlight the expanding role of targeted therapies in managing dermatologic conditions in patients with skin of color.

Through real-world clinical scenarios and evidence-based insights, faculty will explore JAK inhibitors, biologics, oral small molecule agents, and emerging therapies—including oral peptides—across a wide spectrum of inflammatory skin diseases. The discussions will emphasize practical clinical decision-making, patient selection, long-term safety, and off-label use in conditions such as atopic dermatitis, psoriasis, vitiligo, hidradenitis suppurativa, alopecia areata, and more.

Faculty will review:

  • How to apply clinical trial data and real-world experience to patients with skin of color
  • Key safety considerations, including black box warnings and risk mitigation
  • Strategies for managing side effects and selecting appropriate patients
  • Insights into novel therapies for inflammatory skin conditions

NON-CME/CE BONUS PRESENTATION

7:00 pm — 8:00 pm
A Clear Choice for Plaque Psoriasis Topical Treatment
This is a Non-CME/CE Presentation
Mona Shahriari, MD, FAAD
Learn about a once-daily, topical treatment without steroids! We’ll explore the clinical safety and efficacy data and how this treatment could fit into your practice.
Sponsored By Arcutis
Arcutis Company Logo

SPEAKER

Mona Shahriari, MD, FAAD

AGENDA

6:00 pm — 7:00 pm
Targeted Therapies and Their Potential Applications in Patients With Skin of Color: Atopic Dermatitis, Psoriasis, & Beyond
Session Introduction
Targeted Therapies for Atopic Dermatitis
Targeted Therapies for Psoriasis & Beyond
Panel Discussion & Audience Q&A
7:00 pm — 8:00 pm
Non-CME/CE Bonus Presentation
8:00 pm — 9:00 pm
Targeted Therapies and Their Potential Applications in Patients With Skin of Color: Vitiligo, Hidradenitis Suppurativa, & Alopecia Areata
Session Introduction
Targeted Therapies for Hidradenitis Suppurativa
Targeted Therapies for Vitiligo & Alopecia Areata
Panel Discussion & Audience Q&A

FACULTY

Andrew F. Alexis, MD, MPH
April W. Armstrong, MD, MPH
Eliot F. Battle, MD
Steven R. Cohen, MD, MPH
Brett King, MD, PHD
Shawn G. Kwatra, MD

REGISTRATION

TARGET AUDIENCE

This activity is intended for Dermatologists, Dermatology Residents/Fellows, Physician Assistants, Nurse Practitioners, Nurses, and other health professionals interested in treating patients with dermatologic diseases.

LEARNING OBJECTIVES

As a result of participating in this activity, participants should be better able to:

  • Differentiate skin color classification systems to categorize common skin disorders and cutaneous diseases in patients with skin of color.
  • Evaluate key differences in the skin structure and how it relates to diagnosing and treating common ethnic skin disorders such as atopic dermatitis, psoriasis, hidradenitis suppurativa, and prurigo nodularis.
  • Identify clinical and diagnostic tools and devices utilized in the diagnosis and management of skin disorders for patients with skin of color.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and National Medical Education Corporation.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses to be determined.
Continuing PA Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 2 Category 1 credits for completing this activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies.  All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
Credit amount subject to change